Description
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
MLN2480 is an oral pan-Raf inhibitor designed to inhibit cell proliferation and survival. MLN2480 is currently in clinical trials and displays anticancer chemotherapeutic activity.
| Cas No. | 1096708-71-2 |
|---|---|
| Purity | ≥98% |
| Formula | C17H12Cl2F3N7O2S |
| Formula Wt. | 506.30 |
| IUPAC Name | 2-[(1R)-1-[(6-amino-5-chloropyrimidine-4-carbonyl)amino]ethyl]-N-[5- chloro-4-(trifluoromethyl)pyridin-2-yl]-1,3-thiazole-5-carboxamide |
| Solubility | DMSO 100 mg/mL (197.51 mM) Ethanol 100 mg/mL (197.51 mM) Water Insoluble |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
http://clinicaltrials.gov/show/NCT01425008
Protein synthesis inhibitor, DPP2 and metallope...
Roscovitine analog; CDK inhibitor.
JAK2 inhibitor.
Furocoumarin; COX-2 inhibitor.
Nucleoside (deoxycytidine) analog; ribonucleoti...
Nonoxynol surfactant.
Calcineurin inhibitor.
Recombinant HIV-1 multi-epitope chimeric antige...
Endogenous peptide neurotransmitter, involved i...
Folic acid derivative
Pyrimidine analog, fluorouracil derivative; thy...
Peptide, neurotensin analog.
JAK2 inhibitor.
c-MET and Ron inhibitor.
MET and Ron inhibitor.
Bisphosphonate, chelating agent.
δ2OR antagonist.
Vitamin A metabolite, differentiation inducer; ...
Salicylic acid prodrug, NSAID; weak COX-1/2 inh...
Diterpene antibiotic produced by Cephalosporum;...